E. Bucci

发表

Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials

G. Cutter, E. Ricci, M. Salvetti, 2021, European journal of neurology.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

A. Marx, S. Muley, R. Conwit, 2019, The Lancet Neurology.

Hypogonadism in DM1 and its relationship to erectile dysfunction

A. Lenzi, N. Vanacore, A. Radicioni, 2011, Journal of Neurology.

A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre

N. Vanacore, A. Botta, M. Garibaldi, 2018, Journal of Neurology.

Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors

S. Boccia, E. Leoncini, S. Gadalla, 2016, Journal of Neurology.

Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case–control study

A. Lenzi, A. Radicioni, M. Garibaldi, 2019, Journal of Endocrinological Investigation.

An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy

C. Piantadosi, G. Novelli, C. Casali, 2016, Neuroepidemiology.

Gender effect on cardiac involvement in myotonic dystrophy type 1

M. Salvetti, L. Leonardi, M. Garibaldi, 2020, European journal of neurology.

Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up

M. Salvetti, L. Leonardi, M. Garibaldi, 2021, Journal of Neurology.

Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity

N. Vanacore, E. Bucci, S. Morino, 2015, Neurology.

Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study

G. Della Marca, G. Silvestri, E. Rastelli, 2019, Journal of the Neurological Sciences.

Erectile dysfunction in myotonic dystrophy type 1 (DM1)

F. Giubilei, G. Novelli, M. Garibaldi, 2009, Journal of Neurology.

Vitamin D deficiency in myotonic dystrophy type 1

M. Morello, O. Porzio, U. Tarantino, 2013, Journal of Neurology.

Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores

E. Bertini, C. Ottenheijm, M. Salvetti, 2020, Neuromuscular Disorders.

Functional MRI changes in the central motor system in myotonic dystrophy type 1.

C. Mainero, P. Pantano, E. Tinelli, 2010, Magnetic resonance imaging.

Dropped-head in recessive oculopharyngeal muscular dystrophy

A. Stoppacciaro, A. Renieri, M. Bruttini, 2015, Neuromuscular Disorders.

Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis

F. Sera, L. Santoro, C. Angelini, 2020, Scientific Reports.

A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes

F. Sera, L. Santoro, C. Angelini, 2016, Journal of Neurology.

Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

F. Sera, L. Santoro, C. Angelini, 2013, Brain : a journal of neurology.

A 5-year clinical follow-up study from the Italian National Registry for FSHD

F. Sera, L. Santoro, C. Angelini, 2020, Journal of Neurology.

Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients.

M. Salvetti, M. Mirabella, L. Leonardi, 2020, Autoimmunity reviews.

Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1–3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry

F. Sera, L. Santoro, C. Angelini, 2016, BMJ Open.

Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy

L. Santoro, D. Bruzzese, C. Angelini, 2020, JAMA network open.

Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.

M. Volpe, G. Piccirillo, D. Magrí, 2012, International journal of cardiology.

“I Know that You Know that I Know”: Neural Substrates Associated with Social Cognition Deficits in DM1 Patients

C. Caltagirone, M. Bozzali, M. Cercignani, 2016, PloS one.

Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus

N. Accornero, F. Giubilei, R. Nemni, 2003, Journal of neurology, neurosurgery, and psychiatry.

Satellite potentials on EMG: Neurophysiologic evidence of axonal transection in MS?

C. Pozzilli, F. Giubilei, A. Paolillo, 2001, Neurology.

15-week long school-based nutritional education program to promote Italian primary schoolchildren's fruit and vegetable intake.

F. Carella, E. Bucci, L. R. Ferguson, 2010, Annali di igiene : medicina preventiva e di comunita.

Reply to the letter entitled “Predictors of respiratory impairment in patients with myotonic dystrophy type 1”

G. Della Marca, G. Silvestri, E. Rastelli, 2019, Journal of the Neurological Sciences.

Distal upper limb involvement in myasthenia-myositis association

M. Salvetti, L. Leonardi, M. Garibaldi, 2022, Neurological Sciences.

Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D 4 Z 4 reduced alleles : experience of the FSHD Italian National Registry

F. Sera, L. Santoro, G. Siciliano, 2016 .

Functional MRI changes in the central motor system in myotonic dystrophy type 1.

C. Mainero, P. Pantano, E. Tinelli, 2010, Magnetic Resonance Imaging.

Vitamin D deficiency in myotonic dystrophy type 1

M. Morello, O. Porzio, U. Tarantino, 2013, Journal of Neurology.